JNJ vs MDT
By Alex · Tickerpine
Johnson & Johnson vs Medtronic plc, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | MDT |
|---|---|---|
| Price | $273.14 | $91.14 |
| Market cap | $658.24B | $116.66B |
| P/E ratio | 31.7 | 24.4 |
| ROE | 25.74% | 9.84% |
| Profit margin | 21.48% | 13.20% |
| Revenue growth | 6.60% | 9.90% |
| Dividend yield | 1.96% | 3.10% |
| Beta | 0.23 | 0.57 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs MDT in plain English
- JNJ is the bigger company — about 5.6× the market cap of MDT.
- MDT is cheaper on earnings (P/E 24.4 vs 31.7).
- JNJ earns a higher return on equity (26% vs 10%).
- MDT is growing revenue faster (10% vs 7%).
- MDT has the higher dividend yield (3.10% vs 1.96%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
MDT return calculator
See what $1,000 in Medtronic plc would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.